Efficacy and Safety of Necitumumab and Pembrolizumab Combination Therapy in Stage IV Nonsquamous Non-Small Cell Lung Cancer (NSCLC)

被引：4

作者：

Besse, Benjamin ^{[1
]}

Garrido, Pilar ^{[2
]}

Puente, Javier ^{[3
]}

Cortot, Alexis ^{[4
]}

Eugenia Olmedo, Maria ^{[2
]}

Perol, Maurice ^{[5
]}

Gil, Maciej ^{[6
]}

Chao, Grace ^{[7
]}

Shahidi, Javad ^{[8
]}

Bennouna, Jaafar ^{[9
]}

机构：

[1] Gustave Roussy, Dept Canc Med, Villejuif, France

[2] Hosp Univ Ramon Y Cajal, Med Oncol Dept, Madrid, Spain

[3] Hosp Clin San Carlos, Med Oncol Dept, Madrid, Spain

[4] Lille Univ Hosp, Thorac Oncol, Lille, France

[5] Ctr Leon Berard, Grp Thorac & Orl, Lyon, France

[6] Eli Lilly, Warsaw, Poland

[7] Eli Lilly & Co, Bridgewater, MA USA

[8] Eli Lilly & Co Bridgewater, Bridgewater, MA USA

[9] Inst Cancerol LOuest, Nantes, France

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

non-small cell lung cancer; Necitumumab; pembrolizumab;

D O I：

10.1016/j.jtho.2016.11.451

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MA09.11

引用

页码：S397 / S397

页数：1

共 50 条

[1] Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)
Besse, B.
Garrido Lopez, P.
Puente, J.
Cortot, A.
Olmedo Garcia, M. E.
Perol, M.
Gil, M.
Chao, G.
Shahidi, J.
Bennouna, J.
ANNALS OF ONCOLOGY, 2017, 28
[2] Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancer
Besse, Benjamin
Garrido, Pilar
Cortot, Alexis B.
Johnson, Melissa
Murakami, Haruyasu
Gazzah, Anas
Gil, Maciej
Bennouna, Jaafar
LUNG CANCER, 2020, 142 : 63 - 69
[3] Safety of necitumumab and pembrolizumab combination therapy in patients with stage IV non-small cell lung cancer (NSCLC): a phase 1b expansion cohort study
Besse, B.
Garrido, P.
Bennouna, J.
Mezquita, L.
Gazzah, A.
Remon, J.
Planchard, D.
Olmedo Garcia, M. E.
Raimbourg, J.
Chao, G. Y.
Gil, M.
ANNALS OF ONCOLOGY, 2016, 27
[4] Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
Besse, Benjamin
Vansteenkiste, Johan
Renault, Patrick-Aldo
Frimodt-Moller, Bente
Chao, Grace
Gil, Maciej
Barlesi, Fabrice
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1227 - S1228
[5] Phase 1b expansion cohort study to evaluate the safety and efficacy of necitumumab and abemaciclib combination therapy in patients with stage IV non-small cell lung cancer (NSCLC)
Besse, B.
Barlesi, F.
Ceccarelli, M.
Chao, G. Y.
Frimodt-Moller, B.
Gil, M.
Vansteenkiste, J.
ANNALS OF ONCOLOGY, 2016, 27
[6] Efficacy and safety of pegvorhyaluronidase alfa (PEGPH20; PVHA) and pembrolizumab (pembro) combination therapy in patients (Pts) with stage III/IV non-small cell lung cancer (NSCLC)
Ward, J. P.
Shum, M.
Bertino, E.
Lin, V.
Kuruvadi, V.
Heineman, T.
ANNALS OF ONCOLOGY, 2019, 30
[7] The safety and efficacy of pembrolizumab for the treatment of non-small cell lung cancer
Mazarico Gallego, Jose Ma
Herrera Juarez, Mercedes
Paz-Ares, Luis
EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 233 - 242
[8] Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Wood, Cameron
Lyniv, Liliana
Isaacs, James M.
Kaufman, Jacob M.
Oduah, Eziafa, I
Clarke, Jeff
Crawford, Jeffrey
Stinchcombe, Thomas
Tong, Betty C.
Wang, Xiaofei
Gu, Lin
Wigle, Dennis
Dragnev, Konstantin H.
Antonia, Scott J.
Weinhold, Kent
Ready, Neal
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)
[9] Therapy of non-small cell lung cancer in stage IV
Deppermann, Karl-Matthias
Huber, Rudolf M.
Laack, Eckart
Reck, Martin
Serke, Monika
von Pawel, Joachim
ONKOLOGIE, 2006, 29 : 15 - 19
[10] Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
Hayashi, Hidetoshi
Kurata, Takayasu
Nakagawa, Kazuhiko
CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 177 - 184

← 1 2 3 4 5 →